Location: Princeton, NJ
CIK: 0001388551 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 14, 2026
Total Value: $4.024M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 20,946 | $41,996 | 1.0% | $1.77 | 0.0% | COM | 00166B105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLD | SPDR GOLD TR | 7,623 (+9.5%) | $3.28M (+18.8%) | 81.5% | $321.04 | — | GOLD SHS | 78463V107 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 727 (+2.4%) | $348K (-2.4%) | 8.7% | $411.72 | +19.9% | CL B NEW | 084670702 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SYRE | SPYRE THERAPEUTICS INC | 8,919 | $292K | 7.3% | $26.13 | +32.2% | — | 00773J202 |
| — | MIND MEDICINE MINDMED INC | 15,688 | $210K | 5.2% | $8.91 | — | — | 60255C885 |
| CMPX | COMPASS THERAPEUTICS INC | 29,495 | $158K | 3.9% | $3.22 | +86.5% | — | 20454B104 |
| SABS | SAB BIOTHERAPEUTICS INC | 10,527 | $39,371 | 1.0% | $2.26 | +77.0% | — | 78397T202 |
| CNTX | CONTEXT THERAPEUTICS INC | 18,403 | $27,053 | 0.7% | $1.72 | +18.9% | — | 21077P108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LXEO | LEXEO THERAPEUTICS INC | 13,943 | $80,032 | 2.0% | $13.31 | -43.4% | COM | 52886X107 |
| KYTX | KYVERNA THERAPEUTICS INC | 18,773 | $162K | 4.0% | $23.94 | -65.3% | COM | 501976104 |
| IKT | INHIBIKASE THERAPEUTICS INC | 28,453 | $47,801 | 1.2% | $2.11 | -17.9% | COM NEW | 45719W205 |
| XFOR | X4 PHARMACEUTICALS INC | 15,557 | $64,249 | 1.6% | $3.63 | +0.1% | COM NEW | 98420X202 |